An interventional study of Multimodal Focal Vibration Therapy (FVT) and Standard Rehabilitation Program in Stroke, Hemiplegic Shoulder Pain and Chronic Stroke Survivors, sponsored by University of Foggia. Not yet recruiting at 1 site in Italy. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-04-07.
Sponsored by University of Foggia · Not applicable, Interventional, and Treatment
Hemiplegic Shoulder Pain (HSP) is a common and disabling complication after stroke, negatively affecting upper limb function, participation in rehabilitation, and quality of life. Despite the widespread use of conservative and physical therapies, evidence supporting the efficacy of specific non-invasive neuromodulation techniques remains limited.
Focal Vibration Therapy (FVT) is a non-invasive physical modality that delivers localized mechanical vibration to targeted muscles or tendons and may modulate pain, muscle tone, and proprioception through frequency-dependent mechanisms.
This randomized controlled trial aims to evaluate the efficacy of a multimodal FVT protocol, in addition to standard rehabilitation, compared with a sham intervention plus standard rehabilitation, in reducing pain in patients with chronic post-stroke Hemiplegic Shoulder Pain.
Hemiplegic Shoulder Pain (HSP) is a frequent and disabling sequela of stroke, with reported incidence rates ranging from 30% to 65% within the first six months after stroke onset. This variability reflects differences in diagnostic definitions and heterogeneity among studied populations. The underlying pathophysiology of HSP is multifactorial, involving musculoskeletal alterations (e.g., glenohumeral subluxation), abnormal nociceptive processing and central sensitization, and spasticity-related impairments, particularly affecting shoulder adductor and internal rotator muscles.
HSP significantly interferes with post-stroke recovery by reducing upper limb motor performance and functional use, impairing participation in rehabilitation programs, and worsening quality of life. Although early and multidisciplinary management is recommended, available therapeutic approaches remain heterogeneous and include positioning strategies, manual therapy, pharmacological treatments, nerve blocks, botulinum toxin injections, dry needling, robotic-assisted therapy, and neuromodulation techniques.
Physical therapeutic modalities are commonly used in rehabilitation settings due to their non-invasive nature and potential analgesic and functional benefits. However, evidence regarding their specific effectiveness in the treatment of HSP is inconsistent, and existing reviews often include heterogeneous interventions or focus on invasive approaches, leaving uncertainty about the role of targeted physical neuromodulation.
Focal Vibration Therapy (FVT) is an emerging physical modality that applies localized mechano-sonic stimulation to muscle bellies or tendon insertions. Its effects are frequency-dependent and include modulation of nociceptive input through spinal gate control mechanisms at low-to-medium frequencies (approximately 35-50 Hz), modulation of muscle tone and proprioception through stimulation of Ia afferent fibers and induction of the tonic vibration reflex at intermediate frequencies (around 100 Hz), and modulation of deep pain perception through activation of Pacinian corpuscles at higher frequencies (approximately 200 Hz).
Given the multifactorial nature of HSP and the limitations of current conservative treatments, there is a need to investigate structured intervention protocols integrating advanced physical modalities with standard rehabilitation. This randomized controlled trial will compare a multimodal FVT protocol, delivered in addition to standard rehabilitation, with a sham intervention plus standard rehabilitation in patients with chronic post-stroke HSP. The study will assess changes in pain intensity as the primary outcome, along with secondary outcomes related to shoulder function, range of motion, spasticity, quality of life, persistence of treatment effects, and safety of the intervention.
Exclusion Criteria:
Participants allocated to the experimental group will receive an integrated treatment consisting of a standardized physiokinesitherapy program followed by active multimodal focal vibration therapy applied to shoulder and peri-scapular muscles involved in hemiplegic shoulder pain.
Device: Multimodal Focal Vibration Therapy (FVT) · Other: Standard Rehabilitation Program
Participants allocated to the control group will receive the same standardized physiokinesitherapy program followed by a sham focal vibration procedure identical in duration and application setting, but without delivery of effective vibratory stimulation.
Other: Standard Rehabilitation Program
Participants in the experimental group will receive multimodal Focal Vibration Therapy (FVT) delivered using a medical vibration device, in addition to standard post-stroke shoulder rehabilitation. FVT will be applied to selected peri-scapular and shoulder muscles involved in pain generation and motor impairment, according to a standardized protocol. Each treatment session consists of two integrated phases. Physiokinesitherapy Phase (30 minutes): Participants will undergo a standardized rehabilitation protocol targeting recovery of the hemiplegic shoulder. Focal Vibration Therapy Phase (25 minutes): Four dome-shaped transducers will be applied directly to the skin over the muscle bellies of Pectoralis Major, Infraspinatus, Middle Deltoid, and Upper Trapezius. The device will deliver a pre-programmed sequence of vibrations consisting of: * 5 minutes at 35 Hz for superficial analgesia * 10 minutes at 100 Hz for muscle tone reduction * 10 minutes at 200 Hz for deep analgesia
All participants will undergo a standardized post-stroke shoulder rehabilitation program, including passive, active-assisted, and active exercises aimed at pain reduction, range of motion recovery, and functional improvement of the affected upper limb. Each session will consist of the same two phases as the experimental group. Physiokinesitherapy Phase (30 minutes): Identical to that administered in the experimental group. Sham Procedure Phase (25 minutes): Four transducers will be positioned on the same shoulder muscle sites as in the experimental group but connected to inactive outputs of the device, delivering no therapeutic vibration. To maintain participant blinding, an additional active transducer will be applied to a distant site, delivering perceptible vibration. Participants will be informed that the device acts through a systemic reflex stimulation mechanism. Device-related noise and tatactile stimulation on the contralateral limb will function as a sensory distractor.
Change in Pain Intensity Assessed by Numerical Rating Scale (NRS)
Change from baseline in pain intensity measured using the Numerical Rating Scale (NRS, 0-10) comparing multimodal Focal Vibration Therapy (FVT) plus standard rehabilitation versus standard rehabilitation plus sham procedure in patients with chronic post-stroke hemiplegic shoulder pain. Pain intensity will be assessed under three standardized conditions to reflect the multidimensional nature of hemiplegic shoulder pain: * Pain at rest (spontaneous pain) * Pain during passive range of motion (pROM) in shoulder flexion and abduction * Pain during active or active-assisted range of motion (aROM) The primary endpoint will be expressed as mean change (Δ score) between T0 and T1.
Time frame: From baseline (Day 0) to the Day 15 (end of treatment)
Change in Shoulder Function and Disability (SPADI)
Change from baseline in total score and subscale scores (Pain and Disability) of the Shoulder Pain and Disability Index (SPADI: range 0-100 where higher scores indicate greater pain and disability), comparing the two study groups across post-treatment and follow-up time points.
Time frame: Baseline (Day 0), Day 15 (end of treatment), and at 1, 3, and 6 months follow-up
Change in Glenohumeral Range of Motion (ROM) (degrees)
Change from baseline in active and passive glenohumeral joint range of motion (ROM), including flexion, abduction, and external rotation, measured in degrees using a standardized universal goniometer. Higher values indicate improved joint mobility.
Time frame: Baseline (Day 0), Day 15 (end of treatment), and at 1, 3, and 6 months follow-up
Change in Upper Limb Spasticity (Modified Ashworth Scale)
Change from baseline in muscle tone assessed by the Modified Ashworth Scale (MAS; range 0-4, where higher scores indicate greater spasticity) in shoulder internal rotators/adductors (Pectoralis Major, Subscapularis)
Time frame: Baseline (Day 0), Day 15 (end of treatment), and at 1, 3, and 6 months follow-up
Change in Health-Related Quality of Life (SF-12)
Change from baseline in physical (PCS) and mental (MCS) health composite scores assessed using the Short Form-12 Health Survey (SF-12; higher scores indicate better health status).
Time frame: Baseline (Day 0), Day 15 (end of treatment), and at 1, 3, and 6 months follow-up
Maintenance of Treatment Effect on Pain (NRS) at Follow-up
Between-group differences in pain intensity measured by the Numerical Rating Scale (NRS, 0-10) at 1, 3, and 6 months after completion of treatment, to assess persistence of treatment effects over time.
Time frame: 1 month, 3 months, and 6 months after end of treatment
Incidence of Adverse Events (AEs) and Device-Related Adverse Events (ADEs)
Number and severity of adverse events (AEs) and device-related adverse events (ADEs) recorded during the study period. Events will be classified according to their relationship to the intervention.
Time frame: From baseline through 6 months follow-up
Plan to share: No
This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Foggia